About Neurolief
Neurolief is a Technology company based in Herzliya (Israel) founded in 2012. It operates as a wearable neuromodulation devices for neurological disorders are developed. It operates in the Technology and Healthcare sectors. Neurolief has raised $11 million across 3 funding rounds from investors including Brainsway and Terra Venture Partners. Neurolief offers products and services including Wearable Neuromodulation Unit, Mobile App, and Cloud-Based Analytics. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is Neurolief Inc. Its competitors include Muse, Flow Neuroscience, Freespira, HypnoVR and Feel Therapeutics and 4 more; 9 of its 9 listed competitors have raised funding.
Company details
Neurolief was founded in 2012 in Herzliya, Israel, within the medical device sector. A wearable platform technology for brain neuromodulation is being developed to treat disorders such as migraine and depression. The device allows treatment without disruption to daily activities and remains in clinical development as of September 2016. Operations focus on safe, effective neurotherapies through non-invasive methods.
- Headquarters Herzliya, Israel
- SectorsTechnologyHealthcare
- Email••••••••
- Website neurolief.com
- Social LinkedIn
- Legal Name Neurolief Inc.
- Total Equity Funding$11M (USD)
in 3 rounds
- Latest Funding Round$6M (USD), Series A
Mar 2026
- InvestorsBrainsway
& 1 more
Products & Services of Neurolief
Neurolief offers a comprehensive portfolio of products and services, including Wearable Neuromodulation Unit, Mobile App, and Cloud-Based Analytics.
Delivers electrical pulses to modulate brain networks for depression relief.
Enables patient therapy tracking and data sharing with physicians.
Supports remote monitoring and treatment customization for depression.
Funding Insights of Neurolief
Neurolief has successfully raised a total of $11M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $6 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11M
- Total Rounds 3
- Last Round Series A — $6M
- Investors Count 2
All 3 funding rounds of Neurolief with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2026 | $6M | Series A | – | – | |
| Aug 2025 | $5M | Series A | – | – | |
| Jun 2015 | – | Seed | – | – |
2 investors in total: 2 institutional.
Investors in Neurolief
Neurolief has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Brainsway and Terra Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | terravp.com | - | |
Develoepr of noninvasive neurostimulation treatments for mental health disorders | 2003 | brainsway.com | Jerusalem, Israel |
Investor details for Neurolief
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Neurolief
10 people are tracked at Neurolief (7 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Shmuel Shany | Co-Founder | Leadership |
Amir Cohen | Director Clinical Development | Leadership |
Anna Minibaev | Head of Design & Product Manager | Leadership |
Michal Kedar-Datel | Vice President Clinical Affairs | Leadership |
Yaron Gruper | Director Of Clinical Affairs | Leadership |
Steve Beller | Chief Commercial Officer (cco) | Leadership |
Sabrina Goldman | Director, Sales Operations & Customer Support | Leadership |
Shany Haikin Franco | CRA and Data Manager | Team |
Rachel Davis | US Field Clinical Specialist | Team |
Mor Ofir | Mobile/Frontend Developer | Team |
Complete people profiles for Neurolief
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Neurolief
3 dated milestones of Neurolief across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Neurolief is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $6.0M.
Competitors of Neurolief
Neurolief has 9 listed competitors in our database, 9 of them funded. They include Muse, Flow Neuroscience, Freespira, HypnoVR and Feel Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| choosemuse.com | 2007 | Toronto, Canada | $58.56M | 49 | EEG-powered headbands for meditation and sleep biofeedback are developed. | |
| flowneuroscience.com | 2016 | Malmo, Sweden | $11.9M | – | Provider of a wearable device for stress and anxiety management | |
| freespira.com | 2008 | Danville, United States | $48.94M | 25 | Panic disorders are treated via breathing device and mobile app. | |
| hypnovr.io | 2016 | Strasbourg, France | $7.77M | – | Virtual reality therapies for pain and anxiety reduction are developed. | |
| feeltherapeutics.com | 2015 | San Francisco, United States | $21.68M | – | Provider of digital Precision Medicine company leveraging objective data and passive measurement for mental healthcare | |
| apolloneuro.com | 2017 | Pittsburgh, United States | $30.66M | 12 | Wearable technology is developed for stress reduction and sleep enhancement. | |
| electrocore.com | 2005 | Basking Ridge, United States | $161.39M | 58 | Non-invasive vagus nerve stimulation devices are developed for headache treatments. | |
| ybrain.com | 2013 | Seoul, South Korea | $3.5M | – | Provider of EEG medical device for major depressive disorder treatment | |
| shiratronics.com | 2019 | Minneapolis, United States | $107.69M | – | Neuromodulation devices for migraine and chronic disease treatment are developed. |
Detailed competitors of Neurolief
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Neurolief
The website of Neurolief (neurolief.com) receives about 5.7K visits a month.
- Monthly visits5.7K
▲ 98.1% vs previous month
Top companies in Sensors & Smart Devices
10 companies that operate in the same segment as Neurolief (Sensors & Smart Devices), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,894 | |
VR-based head-mounted displays for gaming are provided by Oculus. | 2012 | Menlo Park, California, United States | USD 107.05 M | – | – | |
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
Cloud-based business telephony and home security services are provided. | 2004 | Palo Alto, California, United States | USD 87.97 M | USD 273.6 M | 1,190 | |
Cloud-based smart security cameras are manufactured for home use. | 1999 | Provo, Utah, United States | USD 172 M | USD 341.04 M | 11,275 | |
Video streaming devices and platforms are provided by Roku. | 2008 | San Jose, California, United States | USD 213.56 M | USD 4.74 B | 4,473 | |
Provider of hardware and software for monitoring home energy consumption | 2010 | Palo Alto, California, United States | USD 80 M | – | – | |
Developer of LiDAR-based sensors | 2002 | San Francisco, California, United States | USD 129 M | USD 169.38 M | 192 | |
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Metabolic health is tracked via devices and fitness platforms. | 2019 | Bengaluru, Karnataka, India | USD 163.28 M | USD 65.48 M | 274 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neurolief
Complete news archive for Neurolief
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurolief
Neurolief was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Neurolief is headquartered in Herzliya, Israel. It is registered at Herzliya, Central District, Israel.
Neurolief is a funded company, having raised a total of $11M across 3 funding rounds to date.
Neurolief was founded in 2012 in Herzliya, Israel, within the medical device sector. A wearable platform technology for brain neuromodulation is being developed to treat disorders such as migraine and depression. The device allows treatment without disruption to daily activities and remains in clinical development as of September 2016. Operations focus on safe, effective neurotherapies through non-invasive methods.
Neurolief's top competitors include Muse, ShiraTronics and ElectroCore.
Neurolief offers Wearable Neuromodulation Unit, Mobile App, and Cloud-Based Analytics.
Neurolief has 2 investors. Key investors include Brainsway, and Terra Venture Partners.
Neurolief operates through Neurolief Inc..